- Home
- BNGO vs RLYB Comparison
BNGO vs RLYB Comparison
Compare BNGO & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- RLYB
- Stock Information
- Founded
- BNGO 2003
- RLYB 2018
- Country
- BNGO United States
- RLYB United States
- Employees
- BNGO N/A
- RLYB N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- RLYB Health Care
- Exchange
- BNGO Nasdaq
- RLYB Nasdaq
- Market Cap
- BNGO 24.3M
- RLYB 24.1M
- IPO Year
- BNGO 2018
- RLYB 2021
- Fundamental
- Price
- BNGO $2.02
- RLYB $0.56
- Analyst Decision
- BNGO Buy
- RLYB Hold
- Analyst Count
- BNGO 4
- RLYB 2
- Target Price
- BNGO $7.67
- RLYB N/A
- AVG Volume (30 Days)
- BNGO 1.6M
- RLYB 315.1K
- Earning Date
- BNGO 11-12-2025
- RLYB 11-06-2025
- Dividend Yield
- BNGO N/A
- RLYB N/A
- EPS Growth
- BNGO N/A
- RLYB N/A
- EPS
- BNGO N/A
- RLYB N/A
- Revenue
- BNGO $27,426,000.00
- RLYB $761,000.00
- Revenue This Year
- BNGO N/A
- RLYB N/A
- Revenue Next Year
- BNGO $24.54
- RLYB N/A
- P/E Ratio
- BNGO N/A
- RLYB N/A
- Revenue Growth
- BNGO N/A
- RLYB 154.51
- 52 Week Low
- BNGO $1.50
- RLYB $0.22
- 52 Week High
- BNGO $28.12
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- BNGO 39.61
- RLYB 50.25
- Support Level
- BNGO $1.63
- RLYB $0.48
- Resistance Level
- BNGO $1.85
- RLYB $0.60
- Average True Range (ATR)
- BNGO 0.11
- RLYB 0.04
- MACD
- BNGO 0.05
- RLYB -0.00
- Stochastic Oscillator
- BNGO 81.82
- RLYB 47.74
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.